Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Cancer research, Afatinib, ERBB3, ErbB, and Pharmacology.
Pancancer outcome prediction via a unified weakly supervised deep learning model
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
<i>MET</i> Exon 14–altered Lung Cancers and MET Inhibitor Resistance
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers